FeatureName:Cancer|Type:BIN|StatisticMethod:ranktest|GroupComparison:colon/rectum|Statistics:1142.000000|Direction: 1|PValue:0.01747083|FDR:0.2698272;FeatureName:anatomic_organ_subdivision|Type:CAT|StatisticMethod:kruskal|GroupComparison:transverse colon/ascending colon/hepatic flexure/rectum/sigmoid colon/rectosigmoid junction/cecum/descending colon|Statistics:  15.753691|Direction: 1|PValue:0.02746445|FDR:0.4213227;FeatureName:tissue_site|Type:CAT|StatisticMethod:kruskal|GroupComparison:aa/ag/af/a6|Statistics:   8.653628|Direction: 1|PValue:0.03426882|FDR:0.4313129;FeatureName:histological_type|Type:CAT|StatisticMethod:kruskal|GroupComparison:colon adenocarcinoma/rectal adenocarcinoma/rectal mucinous adenocarcinoma/colon mucinous adenocarcinoma|Statistics:   9.211293|Direction: 1|PValue:0.02660962|FDR:0.4063806;FeatureName:history_of_colon_polyps|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics: 696.000000|Direction:-1|PValue:0.04105384|FDR:0.9957516;FeatureName:lymphatic_invasion_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:yes/no|Statistics: 593.000000|Direction:-1|PValue:0.02538210|FDR:0.3528112;FeatureName:lymphnode_pathologic_spread|Type:CAT|StatisticMethod:kruskal|GroupComparison:n0/n1/n2|Statistics:   6.134372|Direction: 1|PValue:0.04655196|FDR:0.3044832;FeatureName:number_of_lymphnodes_positive_by_he|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.272755|Direction:-1|PValue:0.00970916|FDR:0.3583459;FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics:  11.131913|Direction: 1|PValue:0.01103354|FDR:0.1278052;FeatureName:vascular_Invasion|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics: 545.000000|Direction: 1|PValue:0.01842384|FDR:0.5573253;FeatureName:CUBN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 328.000000|Direction:-1|PValue:0.04589013|FDR:0.1876096;FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:1264.000000|Direction: 1|PValue:0.00132175|FDR:0.0168576;FeatureName:FLG_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 312.000000|Direction:-1|PValue:0.02881766|FDR:0.2021084;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.226269|Direction:-1|PValue:0.03402140|FDR:0.0829645;FeatureName:13q12.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.290101|Direction:-1|PValue:0.00611214|FDR:0.0606849;FeatureName:13q12.13_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.270952|Direction:-1|PValue:0.01066857|FDR:0.0823851;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.256737|Direction:-1|PValue:0.01575307|FDR:0.0446873;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.248941|Direction:-1|PValue:0.01934418|FDR:0.0548743;FeatureName:1q31.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.220259|Direction:-1|PValue:0.03920099|FDR:0.2470558;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.302421|Direction: 1|PValue:0.00418617|FDR:0.0193959;FeatureName:14q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.220749|Direction: 1|PValue:0.03875606|FDR:0.2512303